- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Urinary Bladder Neoplasm in United States
Total 64370 results
-
Cedars-Sinai Medical CenterNational Cancer Institute (NCI); VA Long Beach Healthcare System; Nonagen Bioscience...Recruiting
-
Wales Cancer Trials UnitUnknownBladder CancerUnited Kingdom
-
UNC Lineberger Comprehensive Cancer CenterMerck Sharp & Dohme LLC; Syndax PharmaceuticalsActive, not recruitingBladder CancerUnited States
-
King's College LondonRecruitingSurgery | Patient Satisfaction | Patient Preference | Muscle Invasive Bladder Cancer | Sexual WellbeingUnited Kingdom
-
Hoosier Cancer Research NetworkBristol-Myers SquibbCompletedTransitional Cell Carcinoma of the BladderUnited States
-
University of Michigan Rogel Cancer CenterBristol-Myers Squibb; Eli Lilly and Company; National Comprehensive Cancer NetworkCompletedBladder CancerUnited States
-
Power Life Sciences Inc.Not yet recruitingBladder CancerUnited States
-
Cedars-Sinai Medical CenterNational Cancer Institute (NCI); University of California, Los Angeles; University... and other collaboratorsRecruiting
-
Noah Hahn, M.D.Pfizer; Hoosier Cancer Research NetworkTerminatedTransitional Cell Carcinoma of the BladderUnited States, United Kingdom
-
Bioniche Life Sciences Inc.TerminatedCarcinoma in Situ | Neoplasm Recurrence, Local | Bladder Neoplasm | Mycobacterium | Transitional Cell, CarcinomaUnited States, Canada, Poland, Germany, Netherlands, United Kingdom
-
Icahn School of Medicine at Mount SinaiPfizerRecruitingFocus Group | Screening ToolUnited States
-
Abramson Cancer Center at Penn MedicineCompletedBladder CancerUnited States
-
Heat BiologicsTerminatedBladder CancerUnited States
-
Matthew GalskyCelgeneTerminatedBladder CancerUnited States
-
miR Scientific LLCActive, not recruitingBladder CancerUnited States
-
Wake Forest University Health SciencesPfizerTerminatedUrinary Bladder Neoplasms | Ureteral Neoplasms | Urethral NeoplasmsUnited States
-
xCuresTerminatedTransitional Cell Carcinoma | Bladder Cancer | Urothelial Carcinoma | Metastatic Urothelial Carcinoma | FGFR2 Gene Mutation | FGFR3 Gene Mutation | FGFR2 Amplification | Bladder Urothelial Carcinoma | Locally Advanced Urothelial Carcinoma | Refractory Bladder Carcinoma | Refractory Bladder Urothelial Carcinoma and other conditionsUnited States
-
University Health Network, TorontoNational Cancer Institute (NCI)Completed
-
Nucleix Ltd.CompletedBladder CancerUnited States, Canada
-
Cancer Research UKCompleted
-
NanoCarrier Co., Ltd.CompletedSolid TumorsUnited States, Romania, Italy, Bulgaria, Poland
-
Eisai Inc.PharmaBio Development Inc.TerminatedBladder CancerUnited Kingdom, Netherlands, Spain, Germany, United States, Ukraine
-
Mark DewhirstCompletedTransitional Cell Carcinoma of Bladder | Superficial Bladder CancerUnited States
-
Guarionex J. DecastroSanofiActive, not recruitingUrothelial Carcinoma of the Urinary BladderUnited States
-
Aura BiosciencesRecruitingMuscle-Invasive Bladder Carcinoma | Non-muscle-invasive Bladder CancerUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Merck Sharp & Dohme LLC; Astellas Pharma Inc; Seagen Inc.Not yet recruitingBladder Cancer | Urothelial Carcinoma Bladder | High Grade Urothelial CarcinomaUnited States
-
Roswell Park Cancer InstituteRecruitingUrinary Tract Infection | Bladder Carcinoma | Refractory Bladder CarcinomaUnited States
-
Memorial Sloan Kettering Cancer CenterCompleted
-
The Methodist Hospital Research InstitutePfizerRecruitingUrothelial Carcinoma BladderUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)WithdrawnBladder Carcinoma | Post-operative PainUnited States
-
Weill Medical College of Cornell UniversityEli Lilly and CompanyRecruitingBladder CancerUnited States
-
Guangzhou Red Pine Medical Instrument Co., Ltd.University of Washington; University of Texas Southwestern Medical Center; Penn...Not yet recruitingBladder Cancer | Bladder Outlet Obstruction | Renal Disease | Renal Stone | Bladder StoneUnited States
-
Prokarium LtdRecruitingA Phase 1/1b Study of ZH9 Treatment in Patients With Non-Muscle Invasive Bladder Cancer (PARADIGM-1)NMIBC | Non Muscle Invasive Bladder Cancer | High Risk NMIBCUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingNon-Muscle Invasive Bladder Cancer (NMIBC)United States
-
Institute of Cancer Research, United KingdomCompletedBladder CancerUnited Kingdom
-
Bioniche Life Sciences Inc.Withdrawn
-
Brown UniversityCures Within Reach; Lifespan; Legorreta Cancer Center at Brown UniversityRecruitingUrothelial Carcinoma Bladder | Androgen Receptor PositiveUnited States
-
Memorial Sloan Kettering Cancer CenterRockefeller University; Pin Down Bladder Cancer Research FoundationRecruitingNon-muscle Invasive Bladder CancerUnited States
-
Eisai Inc.H3 Biomedicine Inc.Withdrawn
-
Bristol-Myers SquibbPierre Fabre MedicamentCompletedKidney Neoplasms | Transitional Cell Carcinoma | Bladder Cancer | Bladder Neoplasms | Ureter Neoplasms | Neoplasm, BladderUnited States, Spain, Italy, Canada, Indonesia, Singapore, Australia, Austria, France, Greece, Korea, Republic of, Philippines, Sweden, Switzerland, Thailand
-
Anchiano Therapeutics Israel Ltd.TerminatedNon-muscle Invasive Bladder Cancer (NMIBC)United States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Active, not recruitingBladder Cancer | Urothelial Carcinoma BladderUnited States
-
University of OxfordMerck Sharp & Dohme LLCTerminatedNon-muscle Invasive Bladder Cancer (NMIBC)United Kingdom
-
University of BirminghamUnknownBladder CancerUnited Kingdom
-
Institute of Cancer Research, United KingdomUnknown
-
University of California, Los AngelesRecruitingBladder Cancer | Kidney Failure | Bladder, Neurogenic | Bladder DiseaseUnited States
-
Fox Chase Cancer CenterActive, not recruitingUrothelial Carcinoma of the BladderUnited States
-
Loyola UniversityAstellas Pharma IncCompletedOveractive Bladder SyndromeUnited States
-
Theralase® Technologies Inc.University Health Network, Toronto; Pharma eMarketRecruitingNon-Muscle Invasive Bladder Cancer ("NMIBC") Unresponsive/Intolerant to BCGUnited States, Canada
-
Cedars-Sinai Medical CenterNational Cancer Institute (NCI); University of California, San Francisco; Fred... and other collaboratorsActive, not recruitingBladder CancerUnited States, Japan